A substance P antagonist inhibits heat-induced oedema in the rat skinLUNDBERG, J. M; SARIA, A; ROSELL, S et al.Acta physiologica scandinavica. 1984, Vol 120, Num 1, pp 145-146, issn 0001-6772Article

Substance P is markedly increased in plasma of patients with hepatic comaHORTNAGL, H; LENZ, K; SINGER, E. A et al.Lancet (British edition). 1984, Num 8375, pp 480-483, issn 0140-6736Article

Altered responsiveness to substance P and 5-hydroxytryptamine in cat dorsal horn neurons after 5-HT depletion with p-chlorophenylalanineJEFTINIJA, S; RASPANTINI, C; RANDIC, M et al.Brain research. 1986, Vol 368, Num 1, pp 107-115, issn 0006-8993Article

Characterization of a conformationally sensitive TOAC spin-labeled substance PSHAFER, Aaron M; NAKAIE, Clovis R; DEUPI, Xavier et al.Peptides (New York, NY. 1980). 2008, Vol 29, Num 11, pp 1919-1929, issn 0196-9781, 11 p.Article

International symposium on substance P and related peptides : pain, inflammation, visceral and CNS functionsRegulatory peptides. 1993, Vol 46, Num 1-2, issn 0167-0115, 502 p.Conference Proceedings

Calcitonin gene-related peptide is a potent inhibitor of substance P degradationLE GREVES, P; NYBERG, F; TERENIUS, L et al.European journal of pharmacology. 1985, Vol 115, Num 2-3, pp 309-311, issn 0014-2999Article

Selective depletion of substance P-immunoreactive neurones in the transitional zone of the colon in piebald lethal miceBU'LOCK, A. J; VAILLANT, C; DOCKAY, G. J et al.Neurochemistry international. 1984, Vol 6, Num 1, pp 55-61, issn 0197-0186Article

Characterization of the peptide and sensory neurotoxic effects of capsaicin in the guinea pigBUCK, S. H; WALSH, J. H; DAVIS, T. P et al.The Journal of neuroscience. 1983, Vol 3, Num 10, pp 2064-2074, issn 0270-6474Article

Substance P enhancement of passive and active avoidance conditioning in miceSCHLESINGER, K; LIPSITZ, D. U; PECK, P. L et al.Pharmacology, biochemistry and behavior. 1983, Vol 19, Num 4, pp 655-661, issn 0091-3057Article

La substance P = Substance PCESARO, P.Revue neurologique (Paris). 1984, Vol 140, Num 8-9, pp 465-478, issn 0035-3787Article

Avidin binding of biotinylated analogues of substance PLAVIELLE, S; CHASSAING, G; MARQUET, A et al.Biochimica et biophysica acta. 1983, Vol 759, Num 3, pp 270-277, issn 0006-3002Article

Reward for persistence in substance P researchWAHLESTEDT, C.Science (Washington, D.C.). 1998, Vol 281, Num 5383, pp 1624-1625, issn 0036-8075Article

A substance P antagonist not containing D-tryptophanESCHER, E; D'ORLEANS-JUSTE, P; DION, S et al.European journal of pharmacology. 1984, Vol 105, Num 3-4, pp 375-377, issn 0014-2999Article

Antidromic vasodilatation and neurogenic inflammationCHAHL, L. A; SZOLCSANYI, J.Neuroscience letters. 1983, Vol 42, Num 2, pp 219-225, issn 0304-3940Article

Neuronal versus endocrine effects: substance P as an exampleLEMBECK, F.Frontiers of hormone research. 1984, Vol 12, pp 118-122, issn 0301-3073Article

Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptorJOSIEN, H; LAVIELLE, S; BRUNISSEN, A et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 11, pp 1586-1601, issn 0022-2623Article

SYNTHESIS OF PEPTIDES RELATED TO SUBSTANCE P AND THEIR ACTIVITIES AS AGONISTS AND ANTAGONISTSRACKUR G; YAMAGUCHI I; LEBAN JJ et al.1979; ACTA CHEM. SCAND., B; DNK; DA. 1979; VOL. 33; NO 5; PP. 375-378; BIBL. 13 REF.Article

Neural contractions in colonic strips from patients with diverticular disease : role of endocannabinoids and substance PGUAGNINI, F; VALENTI, M; MUKENGE, S et al.Gut. 2006, Vol 55, Num 7, pp 946-953, issn 0017-5749, 8 p.Article

Substance P-like immunoreactivity in the frog dorsal root gangliaKEMALI, M; GIOFFRE, D.Experientia. 1985, Vol 41, Num 4, pp 481-482, issn 0014-4754Article

An ion exchange chromatography and radioimmunoassay procedure for measuring opioid peptides and substance PBERGSTRÖM, L; CHRISTENSSON, I; FOLKESSON, R et al.Life sciences (1973). 1983, Vol 33, Num 16, pp 1613-1619, issn 0024-3205Article

Substance P immunoreactivity in normal human retina and in retinoblastomaTARKKANEN, A; TERVO, T; TERVO, K et al.Ophthalmic research. 1983, Vol 15, Num 6, pp 300-306, issn 0030-3747Article

α-Bungarotoxin interacts with the rat brain tachykinin receptorsUTKIN, YU. N; LAZAKOVICH, E. M; KASHEVEROV, I. E et al.FEBS letters. 1989, Vol 255, Num 1, pp 111-115, issn 0014-5793, 5 p.Article

Partial characterization of immunoreactive substance P in the rat pituitary glandDE PALATIS, L. R; KHORRAM, O; HO, R. H et al.Life sciences (1973). 1984, Vol 34, Num 3, pp 225-238, issn 0024-3205Article

Enzymkatalysierte Synthesen N-geschützter C-terminaler Substanz P-Teilsequenzen = Synthèse enzymatique de séquences C-terminales N-protégées de la substance P = Enzyme-catalyzed syntheses of N-protected C-terminal substance P partial sequencesKUHL, P; DÖRING, G; NEUBERT, K et al.Pharmazie. 1984, Vol 39, Num 12, pp 814-816, issn 0031-7144Article

Characterization and partial purification of a 5,700 dalton form of substance P-like immunoreactivity from the rat hypothalamusHARMAR, A. J; ARMSTRONG, A; CHI-MING LEE et al.Brain research. 1984, Vol 323, Num 2, pp 342-344, issn 0006-8993Article